{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:05:11Z","timestamp":1791108311354,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"vor","delay-in-days":3929,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1111\/j.1600-6143.2011.03914.x","type":"journal-article","created":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T14:04:56Z","timestamp":1328191496000},"page":"630-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":243,"title":["Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys"],"prefix":"10.1016","volume":"12","author":[{"given":"J.O.","family":"Medina Pestana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Grinyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Vanrenterghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Campistol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Florman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.D.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.","family":"Manfro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Massari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.C.","family":"Rial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vitko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.B.","family":"Harler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Durrbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2011.03914.x_bib1","first-page":"11","article-title":"Renal transplantation from extended criteria cadaveric donors: Problems and perspectives overview","volume":"21","author":"Audard","year":"2008","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/TP.0b013e31819ec3a6","article-title":"Outcomes of transplantation using kidneys from donors meeting expanded criteria in Australia and New Zealand, 1991 to 2005","volume":"87","author":"Collins","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1600-6135.2005.00835.x","article-title":"Current status of kidney and pancreas transplantation in the United States, 1994\u20132003","volume":"5","author":"Danovitch","year":"2005","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"10.1111\/j.1600-6143.2011.03914.x_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1034\/j.1600-6143.3.s4.11.x","article-title":"Expanded criteria donors for kidney transplantation","volume":"3","author":"Metzger","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1681\/ASN.V123589","article-title":"Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates","volume":"12","author":"Ojo","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib6","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/00007890-200211150-00014","article-title":"Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors","volume":"74","author":"Port","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib7","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1111\/j.1600-6143.2007.01993.x","article-title":"Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: Realities and costs","volume":"7","author":"Saidi","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(84)91166-8","article-title":"Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: Beneficial effect of low doses in early post-transplantation period","volume":"2","author":"Klintmalm","year":"1984","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib10","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","article-title":"Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure","volume":"90","author":"Gaston","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1034\/j.1600-6143.2002.20902.x","article-title":"Cardiovascular toxicities of immunosuppressive agents","volume":"2","author":"Miller","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib13","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long-term kidney transplant survival","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib16","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2165\/00003495-200767110-00005","article-title":"Renal transplantation in high-risk patients","volume":"67","author":"Weimert","year":"2007","journal-title":"Drugs"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-6143.2005.00749.x","article-title":"Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties","volume":"5","author":"Larsen","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib19","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/TP.0b013e3181ff87cd","article-title":"Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies","volume":"90","author":"Larsen","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/TP.0b013e3182007b95","article-title":"An integrated safety profile analysis of belatacept in kidney transplant recipients","volume":"90","author":"Grinyo","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib23","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the modification of diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values","volume":"53","author":"Levey","year":"2007","journal-title":"Clin Chem"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2011.03914.x_bib24","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib25","unstructured":"United States Department of Health and Human Services. The U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. 2007 Annual Report. http:\/\/www.optn.org\/AR2007\/default.htm."},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib26","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1681\/ASN.2009111109","article-title":"Five-year safety and efficacy of belatacept in renal transplantation","volume":"21","author":"Vincenti","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2S","key":"10.1111\/j.1600-6143.2011.03914.x_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00007890-201007272-00639","article-title":"Application of a validated long-term renal transplant graft survival prediction model to expected belatacept phase III trial outcomes","volume":"90","author":"Schnitzler","year":"2010","journal-title":"Transplantation"},{"issue":"S2","key":"10.1111\/j.1600-6143.2011.03914.x_bib28","first-page":"353","article-title":"Expected median graft survival prediction for belatacept Phase III trial outcomes in kidney transplantation","volume":"11","author":"Schnitzler","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib63","unstructured":"2007 Annual Report of the OPTN and SRTR: Chapter VIII calculating life years from transplant (LYFT): Methods for kidney and kidney-pancreas candidates. 2007. http:\/\/optn.transplant.hrsa.gov\/. Accessed December 15, 2010."},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib30","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1046\/j.1600-6135.2003.00275.x","article-title":"Poor predictive value of serum creatinine for renal allograft loss","volume":"3","author":"Kaplan","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/j.ajkd.2010.10.054","article-title":"On behalf of the patient outcomes in renal transplantation (PORT) investigators. The relationship between kidney function and long-term graft survival after kidney transplant","volume":"57","author":"Kasiske","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib32","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/TP.0b013e31821ab993","article-title":"Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs","volume":"91","author":"Schnitzler","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib33","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(10)60827-6","article-title":"Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: A cohort study","volume":"376","author":"Summers","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2011.03914.x_bib34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/j.ajkd.2008.06.005","article-title":"A systematic review of kidney transplantation from expanded criteria donors","volume":"52","author":"Pascual","year":"2008","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2011.03914.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522273559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522273559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2011.03914.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:56:51Z","timestamp":1761627411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522273559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1600613522273559"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03914.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14257049.15768223","asserted-by":"object"}]},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03914.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}